4//SEC Filing
Bellerophon Therapeutics, Inc. 4
Accession 0001179110-15-004962
CIK 0001600132operating
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 5:05 PM ET
Size
5.4 KB
Accession
0001179110-15-004962
Insider Transaction Report
Form 4
MEGLASSON MARTIN
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2015-03-12+8,297→ 8,297 totalExercise: $10.22Exp: 2025-03-11→ Common Stock (8,297 underlying)
Footnotes (1)
- [F1]This option vested as to 25% of the underlying shares on March 13, 2015 (the "Vesting Commencement Date") and vests as to an additional 25% of the underlying shares on each of the first, second and third anniversaries of the Vesting Commencement Date.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001600132
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 5:05 PM ET
- Size
- 5.4 KB